Cargando…
Elevated Hsp90-beta contributes to differential diagnosis of pleural effusion caused by lung cancer and correlates with malignant biological behavior of lung cancer
BACKGROUND: Hsp90-beta has been investigated to be correlated with the occurrence and development of tumor. The intention of this research was to test the level of Hsp90-beta in malignant pleural effusion (MPE) of patients with lung cancer and disclose the clinical significance of Hsp90-beta as a po...
Autores principales: | Biaoxue, Rong, Min, Li, Tian, Fu, Wenlong, Gao, Hua, Liu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6282391/ https://www.ncbi.nlm.nih.gov/pubmed/30522463 http://dx.doi.org/10.1186/s12890-018-0752-z |
Ejemplares similares
-
Thoracic perfusion of matrine as an adjuvant treatment improves the control of the malignant pleural effusions
por: Biaoxue, Rong, et al.
Publicado: (2015) -
Upregulation of Hsp90-beta and annexin A1 correlates with poor survival and lymphatic metastasis in lung cancer patients
por: Biaoxue, Rong, et al.
Publicado: (2012) -
Evaluation of efficacy and safety for recombinant human adenovirus-p53 in the control of the malignant pleural effusions via thoracic perfusion
por: Biaoxue, Rong, et al.
Publicado: (2016) -
Thoracic perfusion of recombinant human endostatin (Endostar) combined with chemotherapeutic agents versus chemotherapeutic agents alone for treating malignant pleural effusions: a systematic evaluation and meta-analysis
por: Biaoxue, Rong, et al.
Publicado: (2016) -
γδT Cells in Lung Cancer Malignant Pleural Effusion: Friend? Foe?
por: Moon, Edmund K.
Publicado: (2019)